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Abstract
Background: Camel mange is an economically important parasitic disease affecting productivity in camel rearing
areas of the world if appropriate treatment is not instituted.
Methods: A cross-sectional and a controlled field trial were carried out to study the epidemiology of camel mange in
Fafan zone, Eastern Ethiopia, and evaluate the efficacy of ivermectin and diazinon in the control of mange infestation
in camels on the basis of clinical and parasitological evidence, respectively. Three groups of naturally infested camels
and one group of healthy camels each composed of 6 individuals were enrolled: the two infested groups received
either ivermectin or diazinon, and the other groups remained untreated.
Results: The overall prevalence rate of mange in camels in the study area was 31.5 % and the only identified species
was Sarcoptes scabiei. The prevalence rate was found to significantly vary (p < 0.05) in relation to body condition and
herd size of camels. Both drugs showed significant variation (p < 0.05) on improving clinical and body condition scores.
Clearance of mange lesions occurred with both drugs; however, re-infestation was observed in diazinon treated group.
Ivermectin significantly improved (p < 0.05) both body condition and clinical scores whereas diazinon markedly
improved only the later.
Conclusion: In conclusion, camels in the study area harbored considerable level of S. scabiei which warrants
institution of an integrated control approach by administration of ivermectin while also sanitating the animal
environment.
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Background
Camel (Camelus dromedarius) is an important livestock
species in the pastoral economy [1], and is commonly
distributed in subtropical dry areas in Africa and Asia
[2]. Ethiopia is one of the largest camel populated coun-
tries in the world. With 1,102,119 numbers of camels,
Ethiopia ranks third in Africa next to Somalia and Sudan
[3]. In arid and semi-arid areas which are not suitable
for crop and animal production, camels are superior to
all other livestock in terms of food security serving as
the main source of milk, meat and draft power [4, 5].
Camel is also a financial reserve and plays an important
role in social prestige and wealth. However, despite its
significant contribution to the livelihood of the pastoral-
ist society, the camel is one of the neglected domestic
livestock by the scientific community [6].
Slow reproduction cycle, high calf mortality and health
problems are major constraints in increasing camel herd
population and productivity. Ectoparasites (mites, ticks
and insects) of the camel and their capacity to disease
transmission are important constraints to productivity
and performance [7]. Camel mange, an extremely conta-
gious ectoparasitism caused by the parasitic mite
Sarcoptes scabiei and transmitted by direct or indirect
contact, is one of the most important parasitic diseases
affecting camel [8].
Significant economic loss of camel productivity to mange
has been recorded [9, 10]. Despite these facts, there is very
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little systematic research on mange and other ectoparasites
of camels in Ethiopia. Few researchers have made attempts
of reporting common ectoparasites affecting camel in
different districts of Eastern Ethiopia [1, 2]. However, infor-
mation on ectoparasitic infestation of camels, especially
mange, in Fafan zone is inadequate despite the compara-
tively large number of these animals in the area, and little
attention has been devoted so far to control of mange in
local camels. The present work was, therefore, carried out
to improve knowledge of the epidemiology of mange in
camels and to evaluate the efficacy of ivermectin and diazi-
non for control of camel mange under field conditions.
Methods
Description of the study area
The study was carried out in selected districts of Fafan
zone, Somali Regional state of Ethiopia. The zone is situ-
ated at 620 km southeast of Addis Ababa, the capital of
the country. It has eight districts, namely Jigjiga,
Kebribeyah, Harshin, Babile, Awbare, Gursum, Tullu
Guled and Gololchen. Temperature of the area is gener-
ally high all the year round with mean minimum and
maximum values being around 20 and 35 °C, respectively.
The mean annual rainfall is 660 mm and bimodal. The
camel population of the zone is 81,221 [11]. The liveli-
hood of the community is based mainly on pastoralism
(34.1 %), agro-pastoralism (56.8 %) and sedentary produc-
tion systems (9.1 %) [12].
Study design and period
The study was carried out from November 2014 to April
2015. A cross-sectional study design was employed for
the epidemiological study and an experimental study
design (controlled field trial) was used for the thera-
peutic study on selected camel herds.
Epidemiological study
Study population and sample size determination
Babile, Kebribeyah and Gursum districts were selected
based on high camel population, accessibility and conveni-
ence. Six kebelles/peasant associations (PAs), two from
each district, were identified. Then, camel herds were se-
lected using simple random sampling method [13], whereas
subjects within herd were selected using systematic random
sampling method [14]. Animals above 1 year old were in-
cluded in this study irrespective of their sex, body condition
score and husbandry condition. Camel herds were visited
and sampled early in the morning before being released to
field, and samples were then taken to Jigjiga University
Veterinary Laboratory Centre.
The sample size was determined based on the formula
recommended by Thrusfield [15] as follows:
N ¼ 1:96ð Þ
2  Pexp  q
d2
Where,
N sample size required
Pexp expected prevalence
q 1-Pexp
d desired absolute precision
Sample size determination was based on 25.9 %
expected prevalence according to Abebe [2] with 5 %
precision and 95 % level of significance. Accordingly, the
sample size required for this study was 295. The propor-
tional probability to size approach [16] was used to
determine the number of camels to be included from
each district. Analyzed risk factors included: sex, age,
body condition score, origin and herd size.
Examination for mange mites
Skin scrapings from clinically suspected cases of mange
were collected and preserved in 10 % formalin. 10 %
potassium hydroxide (KOH) was then added to the sedi-
ment to digest or clean the scraped material of skin, hair
and other debris, so that mites were released from scabs.
Finally, the specimens were carefully placed on slides for
microscopic examination (40× or 100× magnification).
Identification of the mange mite species was based on
the morphological characteristics described by Urquhart
et al. [17].
Age determination
Age was determined by dental eruption according to
Khan et al. [18]. Camels were divided into two age cat-
egories (>3 year and ≤ 3 year) based on their puberty
profile [19].
Body condition scoring
The body conditions of sampled camels were categorized
as good, medium and poor according to Faye et al. [20].
Assessment was made on days 0, 7, 14, 21, 28, 42 and 56
for all groups.
Therapeutic study
This controlled field trial was carried out on camels natur-
ally infested with mange mites. After conducting the
epidemiological survey, four camel herds were selected for
the therapeutic study based on their appropriateness for
the experiment. This was based on communities’ com-
plaints on intensity of the disease, personal observations
during the field work, accessibility, number of affected
camels in the specific village, and owners’ compliance.
Overall, three groups of naturally infested camels and one
group of healthy (uninfested) camels each composed of 6
animals were enrolled. Grouping was by random selection
of the animals. During the therapeutic trial, camels in all
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groups were kept under traditional management system
with similar husbandry facilities extended to them. They
were allowed for free grazing in feed abundant areas usu-
ally mixed with other livestock.
Clinical examination and scoring of skin lesions
All camels were subjected to whole body examination
for clinical signs of mange (erythema, pruritus, alopecia,
hyperpigmentation and crusting) and clinically scored
according to a system previously applied to horses with
chorioptic mange [21]. Briefly, blinded clinical dermato-
logical assessments (severity of the lesions and degree of
recovery if any) were taken on days 0, 7, 14, 21, 28, 42
and 56 for all groups and scores were recorded as fol-
lows: 0: no clinical signs; 1: mild signs and high degree
of recovery; 2: moderate signs and degree of recovery;
and 3: severe signs and low degree of recovery.
Parasitological examination
Prior to enrollment in the study, the camels were tested
for presence of mites (larvae, nymphs and adults) in skin
scrapings obtained from at least 3–4 sites. Scrapings (see
above) were performed on days 0, 7, 14, 21, 28, 42 and
56 of treatment at those sites where suspected lesions
were present, and in selected healthy sites (the head,
base of the neck, mammary gland, prepuce and flank)
most likely to yield mites.
Therapy protocols
The camels with typical lesions of mange, harboring mites,
were divided and randomly assigned by coin toss into 3
groups, and for comparisons, a fourth group of healthy
camels were also included. Two miticidal agents, ivermectin
(Ivomec, Change QiankumaVeterinary Pharmaceutical, Co.
Ltd., China) and diazinon (Diazinol, E.C, Company Kat
Relzayat, Pesticides and Chemical, Co. Ltd., Egypt) were
chosen for this field trial based on their commercial avail-
ability, patronage by camel herders and veterinary clinics in
the study area, and recommendation from literature.
Camels in group I received diazinon 10 days apart at a con-
centration of 0.1 % (spray), whereas camels under group II
received two doses of ivermectin 10 days apart at dose rate
of 0.2 mg kg−1 of body weight (subcutaneous injection).
Group III (infested) and group IV (healthy) were left as
positive and negative control with no treatment applied.
The efficacy of each regimen was evaluated on the basis of
clinical and parasitological evidence on day zero (day of
treatment) and on days 7, 14, 21, 28, 42 and 56 post-
treatment.
Ethical approval
Ethical approval was obtained from Directorate of
Research, Publication and Technology Transfer Research
Ethics Committee, Jigjiga University, Ethiopia.
Statistical analysis
For both the epidemiological and therapeutic studies,
data was organized, edited and analyzed using statistical
package for social sciences (SPSS), Version 20. The
prevalence of mange was assessed using descriptive
statistics. To assess differences in the prevalence and
frequency of mange and association of potential risk
factors (sex, age, body condition, herd size and origin)
with the prevalence, the Chi-square (X2) test was used.
Table 1 Prevalence of mange infestation in camels of the study area, on the basis of different risk factors
Variable Category level Number examined Number positive (%) X2 p-value
El-bahay 45 17 (38 %)
Kollej 50 12 (24 %)
Place of origin Arro-aska 47 17 (36.17 %) 4.29 0.58
Gol-marodi 46 11 (24.1 %)
Guyow 50 18 (32.70 %)
Garbo-hare 57 18 (36 %)
Sex Male 84 27 (32.1 %) 0.021 0.885
Female 211 66 (31.1 %)
Age >3 year 223 72 (32.2) 0.245 0.620
≤3 year 72 21 (29.16)
Good 110 18 (16.3)
Body condition Medium 148 53 (35.8) 26.34 <0.001
Poor 37 22 (59.5)
<20 107 24 (22.4) 16.22 <0.001
Herd size 20–40 136 41 (30.1)
>40 52 28 (53.8)
Feyera et al. Parasites & Vectors  (2015) 8:612 Page 3 of 6
For the therapeutic study, results and data generated
from the trial were expressed as mean ± standard error.
One way analysis of variance (ANOVA) and the student
t-test was employed for inter-group and intra-group dif-
ference analysis. Results were deemed statistically signifi-
cant if p ≤ 0.05 at 95 % confidence intervals.
Results
Epidemiological study
The present study revealed that camels of the study area
are remarkably exposed to mange caused by sarcoptic
mites. An overall prevalence of 31.5 % was recorded
(Table 1). S. scabiei was identified as the only mite
species in all skin scrapings collected from the suspected
lesions of examined camels. Analysis results revealed no
statistically significant difference related to origin, sex
and age categories of the studied camels. As opposite,
herd size and poor body condition score were signifi-
cantly (P < 0.001) and positively associated to mange
prevalence.
Therapeutic study
Treatment with ivermectin and diazinon was similarly
effective on sarcoptic mange infestation, and beneficial
on clinical and body condition scores. Both treatments
resulted in the clearance of skin of mangy camels
(Table 2). No parasitic stages were found throughout the
observation period post application of ivermectin. How-
ever, reinfestation was observed in a camel during the
8th week post diazinon application. Furthermore, one of
the healthy untreated animals was found infested with
mange at the end of the observation period.
Throughout the observation period, treatment with
either drug did not result in significant improvement in
the body condition score compared to pre-treatment
values and amongst themselves (Table 3). Relative to
positive controls, treatment with ivermectin seemed to
improve the body condition score (28 through 56 days
post-treatment; p < 0.05), whereas the diazinon group
had a similar body condition score except in week 7.
The positive and negative controls showed deteriorating
and stable body condition scores, respectively.
Treatment with either drug resulted in a considerable
improvement in the clinical score compared with pre-
treatment values and the positive controls (Table 4). Dif-
ferences were statistically significant from the third week
post treatment to the end of the trial. All treated camels
showed high degree of recovery with reference to skin
texture, healing of skin lesions and disappearance of
crusts. However, the infested untreated camels showed
worsening skin appearance compared to the treated
groups.
Discussion
The present study demonstrated an overall prevalence of
31.5 % mange mite infestation in the studied camel
herds. This value is higher than the figure in Awol et al.
[22], Dinka et al. [1], Lawal et al. [23] and Chaudhry
et al. [24] who reported 16.7, 10.7, 3.5 and 3.14 % preva-
lence from Northern Ethiopia, Eastern Ethiopia, Sokoto-
Nigeria and Cholistan-Pakistan, respectively and lower
than a prevalence of 83 % reported by Al-ani et al. [25]
in Jordan. Variation in genetics, environment, accessibil-
ity to veterinary services, herd size and other husbandry
practices could justify these differences.
Table 2 Effect of ivermectin and diazinon treatment on mange infestation in camels
Group D0 D7 D14 D21 D28 D42 D56
NPA ENM NPA ENM NPA ENM NPA ENM NPA ENM NPA ENM NPA ENM
Ivermectin 6 ++ 0 – 0 – 0 – 0 – 0 – 0 –
Diazinon 6 ++ 0 – 0 – 0 – 0 – 0 – 1 +
Infested untreated 6 ++ 6 + 6 ++ 6 + 0 + 6 ++ 6 ++
Healthy untreated 0 – 0 – 0 – 0 – 0 – 0 – 1 +
+: 1–10 mites; ++: 10–100 mites; −: No mites; n (number of animals in each group) = 6; D = day; D0 = the day treatment commenced; NPA = Number of Positive
animals; ENM = Estimated number of mites
Table 3 Effect of ivermectin and diazinon treatment on body condition score change of experimental camels
Goup D0 D7 D14 D21 D28 D42 D56
Ivermectin 1.83 ± 0.17 1.67 ± 0.21 1.67 ± 0.21 2.17 ± 0.17 2.33 ± 0.21a 2.50 ± 0.22a 2.50 ± 0.22a
Diazinon 2.00 ± 0.26 2.00 ± 0.26 2.17 ± 0.17 2.00 ± 0.26 2.67 ± 0.21 2.33 ± 0.21a 2.00 ± 0.26
Infested untreated 2.00 ± 0.00 1.83 ± 0.17 1.83 ± 0.17 1.50 ± 0.22 1.50 ± 0.22 1.33 ± 0.21 1.50 ± 0.22
Healthy untreated 2.33 ± 0.21 2.67 ± 0.17 2.67 ± 0.17 2.67 ± 0.17 2.33 ± 0.21a 2.67 ± 0.17a 2.67 ± 0.17
Values are mean ± SEM; n (number of animals in each group) = 6; D = day; D0 = the day treatment commenced; SEM = standard error of mean; all superscripts
indicate significance at p < 0.05 (acompared to infested untreated)
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S. scabiei was identified as the only mite species in all
scrapings collected from suspected skin lesions. This ob-
servation is in general agreement with reports by various
authors [1, 22, 23]. Even though both sarcoptic and
chorioptic mange mites have been reported, sarcoptic
mange caused by S. scabiei is by far the most common,
contagious and serious condition in camels [26, 27].
Similarly as Megersa et al. [28] and Dinka et al. [1] from
southeastern and eastern Ethiopia, respectively, the
prevalence of mange did not differ according to the ori-
gin, sex, and age of the camels. Not surprisingly, mite
prevalence was highest in camels with poor body condi-
tion score (59.4 %). Moreover, the prevalence of S.
scabiei increased significantly in herds with a larger size.
Probably, camels living in larger herds are more prone
to come into contact with infested animals, e.g., during
herding, housing and suckling.
Amongst factors that may influence the condition of
camels, control of ectoparasites with effective chemicals
such as endectocides and ectoparasiticides is very im-
portant. These drugs can be used for the benefit of local
epidemiological awareness [29]. In the present work,
their efficacy was evaluated on the basis of clinical im-
provement and the parasitological findings. Data re-
vealed that the clearance of skin of infested camels
occurred following either treatments (with ivermectin
and diazinon). Successful use of ivermectin in mangy
camels at a dose rate of 200 μg/kg body weight has been
reported [30]. In the present study, mangy animals
treated with ivermectin felt rapidly more comfortable
and docile due to quicker relief from itching.
While no lesions were found during microscopic
examination of the skin scrapings up to the 7th week
post treatment with diazinon, re-infestation was ob-
served at the 8th week with resurgence of the typical
mangy skin lesions. As opposite, the animals treated
with ivermectin neither showed any lesions nor signs of
re-infestation throughout the observation period after
treatment. The result of the present work also agrees
with the reports of Bala and Rath [31] and Abdally [29],
who stated that ivermectin have good efficacy against
sarcoptic mites. Sprays such as diazinon have also been
used to clean the animal environment to eliminate the
risk of recurrent infestation from fomites [32, 33]. Saber
and Ahmed [34] suggested that using acaricides for
treatment in addition to spraying animal environment
(bedding, wall and fomites) is the best protocol for con-
trolling mange in water buffaloes.
In this field trial, the treated camels were not isolated
from the herd, hence they had opportunity of contact
with other sick animals and a contaminated environ-
ment. It was, thus, impossible to tell how and when they
became re-infested. However, the results of this study
demonstrated that re-infestation may occur if treated an-
imals are not isolated from untreated similars or infected
premises and environment [35].
Conclusion
The present study conducted in Fafan zone, eastern
Ethiopia showed that camels living in this area are fre-
quently infested with mange mites with a likely impact
on their health and productivity. The overall prevalence
of mite infestation was 31.5 %, S. scabiei being the only
mite found in affected camels. Origin, sex and age were
not significantly associated with the prevalence of mange
mite infestation, while a positive association existed with
poor body condition and herd size. The therapeutic field
trial showed obvious clinical improvement in all the
treated camels. The study also revealed that ivermectin
was relatively more efficacious than diazinon, as mea-
sured by analyses of skin scrapings, and body condition
and clinical score changes.
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